Literature DB >> 21515855

Ipilimumab approved for metastatic melanoma.

Kate Traynor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21515855     DOI： 10.2146/news110025

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  10 in total

Review 1.  Tumor control versus adverse events with targeted anticancer therapies.

Authors:  Dorothy M K Keefe; Emma H Bateman
Journal:  Nat Rev Clin Oncol       Date:  2011-12-20       Impact factor: 66.675

2.  Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm.

Authors:  Jagpal S Klair; Mohit Girotra; Laura F Hutchins; Kari D Caradine; Farshad Aduli; Mauricio Garcia-Saenz-de-Sicilia
Journal:  Dig Dis Sci       Date:  2016-02-05       Impact factor: 3.199

3.  Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients.

Authors:  Brendan Fong; Richard Jin; Xiaoyan Wang; Michael Safaee; Dominique N Lisiero; Isaac Yang; Gang Li; Linda M Liau; Robert M Prins
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

Review 4.  Cutaneous melanoma: new advances in treatment.

Authors:  Michele Ceolin Foletto; Sandra Elisa Haas
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

Review 5.  Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme.

Authors:  Liu Yang; Geng Guo; Xiao-yuan Niu; Jing Liu
Journal:  Biomed Res Int       Date:  2015-06-17       Impact factor: 3.411

6.  Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib.

Authors:  Elzbieta Nowara; Joanna Huszno; Grzegorz Slomian; Jaroslaw Nieckula
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

7.  Efficacy and Safety of Immune Checkpoint Inhibitors for Advanced Malignant Melanoma: A Meta-Analysis on Monotherapy Vs Combination Therapy.

Authors:  Jnaneshwari Pradeep; Thin Thin Win; Saint Nway Aye; Chandrashekhar T Sreeramareddy
Journal:  J Cancer       Date:  2022-08-08       Impact factor: 4.478

8.  Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.

Authors:  Marcelo Freitas; Suzana Malheiros; João Norberto Stávale; Thais Priscila Biassi; Fernando Tadeu Zamunér; Maria de Souza Begnami; Fernando Augusto Soares; Andre Luíz Vettore
Journal:  Oncotarget       Date:  2013-04

9.  Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.

Authors:  Richard G Everson; Richard M Jin; Xiaoyan Wang; Michael Safaee; Rudi Scharnweber; Dominique N Lisiero; Horacio Soto; Linda M Liau; Robert M Prins
Journal:  J Immunother Cancer       Date:  2014-05-13       Impact factor: 13.751

10.  SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Authors:  Daniela Bianconi; Merima Herac; Daniel Spies; Markus Kieler; Robert Brettner; Matthias Unseld; Katrin Fürnkranz; Barbara Famler; Margit Schmeidl; Christoph Minichsdorfer; Christoph Zielinski; Gerwin Heller; Gerald W Prager
Journal:  Transl Oncol       Date:  2018-09-20       Impact factor: 4.243
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.